Disclaimer: This article is only for learning and communication by medical professionals. The content may cause discomfort. Non-professionals should read it with caution. This article should not be regarded as providing any medical advice or treatment plan. If you need medical advice or treatment plan, please go to the hospital to consult a practicing physician.
From October 14 to 20, 2024, the 2024 Nanjing Drum Tower Hospital Single-port Bariatric Surgery Forum was grandly held in Nanjing, the ancient capital of the Six Dynasties. The forum is divided into two parts: October 14-18 is an online live broadcast of surgery, and October 20 is an offline academic conference.
With the development of bariatric metabolic surgery technology, single-port bariatric surgery can achieve the goal of weight loss and blood sugar reduction while better meeting the patient's aesthetic and privacy needs. Therefore, it has attracted increasing attention and has developed rapidly in recent years. The 2024 Nanjing Gulou Hospital Single-port Bariatric Surgery Forum aims to build an academic exchange platform, invite experts and scholars from all over the country to participate in discussions, share the latest research results, and jointly promote the development of single-port bariatric surgery technology.
During the live surgery session from October 14 to 18, the expert teams from the Plastic Surgery Hospital of the Chinese Academy of Medical Sciences, the East China Hospital of Fudan University, the First Affiliated Hospital of Nanjing Medical University, the Fourth Affiliated Hospital of China Medical University, the Affiliated Hospital of Nantong University, the First Affiliated Hospital of Jinan University, and Nanjing Drum Tower Hospital respectively performed live single-port laparoscopic sleeve gastrectomy surgeries. Among them, the expert teams from the First Affiliated Hospital of Nanjing Medical University, the Fourth Affiliated Hospital of China Medical University, and Nanjing Drum Tower Hospital used the domestic innovative product Vidasis SIS Stapleline Reinforcement in the live surgery.
We can see in the live video of the operation that the Vidasis SIS Stapleline Reinforcement has a good effect during the operation, the stapler is fired smoothly, the sleeve gastrectomy margin is clean and smooth, there is no small blood vessel bleeding or staple bursting, the occurrence of anastomotic bleeding and postoperative anastomotic leakage complications is reduced, and the safety of sleeve gastrectomy is further ensured.
At the offline academic conference on October 20, more than 30 experts in the field of weight loss and metabolism from major hospitals across the country attended the meeting to share and discuss the topic of single-port weight loss surgery.
As leaders in the field of weight loss and metabolism, the speakers shared the operating techniques, challenges and coping strategies of single-port sleeve gastrectomy based on their rich clinical surgical experience. They also conducted a systematic and comprehensive comparison of the advantages and disadvantages of single-port, double-port and triple-port sleeve gastrectomy, and discussed the difficulties and pain points encountered in single-port sleeve gastrectomy.
During the sharing, many experts mentioned the Borriqiang® Vidasis SIS Stapleline Reinforcement, believing that the use of the Borriqiang® Anastomosis Reinforcement Patch further ensures the safety of the operation and shortens the surgical suture time.
The experts' sharing was brilliant and the sparks of ideas kept colliding. Through continuous exploration, sharing, discussion and collision, a series of effective solutions were summarized, which provided valuable reference for the participants, jointly promoted the development of single-port weight loss surgery, and brought good news to more obese patients.
In addition, Biosis Healing set up a booth at the conference site to show the experts present the Borrqiang®Vidasis SIS Stapleline Reinforcement and its clinical application in weight loss surgery. This innovative product attracted the attention of many experts present. Through the product explanation and simulation demonstration by the on-site staff, the product's excellent material performance, convenient operation design, and simulated actual clinical application effects were demonstrated, which won wide attention from the experts and industry peers present.
The Boruiqiang® Vidasis SIS Stapleline Reinforcement is a product approved by the National Medical Products Administration for innovative medical devices (No. 1, 2018), and is made of SIS materials with independent intellectual property rights. The product can be used with all mainstream brands of staplers on the market to reinforce the anastomotic site, effectively reducing the occurrence of anastomotic bleeding and postoperative anastomotic leakage complications during gastrointestinal surgery, as well as reinforcing the anastomotic site and preventing air leakage during lung surgery.
The material is rich in bioactive substances, which accelerates the healing of the anastomosis. It does not contain cross-linking agents, and the implanted material can be completely degraded and absorbed with tissue regeneration. Fewer electrocoagulation hemostasis operations can save doctors time for hemostasis and suture reinforcement during surgery. Excellent material performance and suture retention, no contracture after implantation, will not cause stenosis of the anastomosis site, and reduce the damage caused by the stapler cutting the tissue. The thin and uniform material thickness does not affect the stapler firing operation and staple forming.
The use of Borriqiang® Vidasis SIS Stapleline Reinforcement during surgery can achieve hemostasis and anastomotic reinforcement through physical reinforcement and endogenous induced tissue repair, reduce the incidence of postoperative bleeding and anastomotic leakage, shorten the operation and hospitalization time, and accelerate patient recovery.
